A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 109, Issue , 2016, Pages 1-7

  Mehler, Stephen J ^a,b   May, Lauren R ^a   King, Crystal ^b   Harris, William S ^c   Shah, Zubin ^d  

^a Hope Veterinary Specialists   (United States)

^b Veterinarian Recommended Solutions   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alpha linolenic acid; Arachidonic acid; Docosahexaenoic acid; Dogs; Eicosapentaenoic acid; Osteoarthritis; Polyunsaturated fatty acid

Indexed keywords

ARACHIDIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PLACEBO; POLYUNSATURATED FATTY ACID; ARACHIDONIC ACID; DRUG COMBINATION;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ARTICLE; AUSTRALIAN SHEPHERD; BASSETHOUND; BERNESE MOUNTAIN; BICHIN FRISE; BOUVIER DES FLANDER; BULLDOG; CHIHUAHUA; CLINICAL TRIAL (TOPIC); COCKAPOO; DIARRHEA; DISEASE SEVERITY; DOG; DRUG EFFICACY; DRUG RESPONSE; FATTY ACID BLOOD LEVEL; FEMALE; GERMAN SHEPHERD; GERMAN SHORTHAIR POINTER; GIANT SCHNAUZER; GOLDEN RETRIEVER; GREAT DANE; HUSKY; KING CHARLERS CAVALIER; LABRADOR RETRIEVER; MALE; MINIATURE SCHNAUZER; MONGREL DOG; NONHUMAN; OLD ENGLISH MASTIFF; OSTEOARTHRITIS; PIT BULL TERRIER; POMERANIAN; POODLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUG; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHETLAND SHEEPDOG; SHIBA INU; SMOOTH COATED COLLIE; TREATMENT DURATION; TREATMENT OUTCOME; WELSH CORGI; WIRE POINTING GRIFFON; ANIMAL; BLOOD; DIET THERAPY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; RANDOMIZATION; VETERINARY;

ANIMALS; ARACHIDONIC ACID; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOGS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; OSTEOARTHRITIS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 84962136083     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2016.03.015     Document Type: Article

References (39)

1. Johnston S.A. Osteoarthritis. Joint anatomy, physiology, and pathobiology. Vet.- Clin. North Am. Small Anim. Pract. 1997, 27:699-723.
2. Roush J.K., Dodd C.E., Fritsch D.A., et al. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. J. Am. Veter-. Med. Assoc. 2010, 236:59-66.
3. Henrotin Y., Sanchez C., Balligand M. Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. Veter-. 2005, 170:113-123.
4. Hauser R.A. The accelerstion of articular cartilage degeneration in osteoarthritis by nonsteroidal anti-inflammatory drugs. J. Prolotherapy 2010, 2:305-322.
5. Bauer J.E. Therapeutic use of fish oils in companion animals. J. Am. Veter-. Med. Assoc. 2011, 239:1441-1451.
6. Fritsch D., Allen T.A., Dodd C.E., et al. Dose-titration effects of fish oil in osteoarthritic dogs. J. Veter-. Intern. Med. 2010, 24:1020-1026.
7. Fritsch D.A., Allen T.A., Dodd C.E., et al. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. J. Am. Veter-. Med. Assoc. 2010, 236:535-539.
8. Roush J.K., Cross A.R., Renberg W.C., et al. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J. Am. Veter-. Med. Assoc. 2010, 236:67-73.
9. Adas F., Berthou F., Salaun J.P., Dreano Y., Amet Y. Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A. Toxicol. Lett. 1999, 110:43-55.
10. Bibus D.M., Stitt P.A. Metabolism of alpha-linolenic acid from flaxseed in dogs. World Rev. Nutr. Diet. 1993, 83:186-198.
11. Wang C., Harris W.S., Chung M., et al. n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary and secondary prevention studies: a systematic review. Am. J. Clin. Nutr. 2006, 84:5-17.
12. Duda M.K., O'Shea K.M., Tintinu A., et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc. Res. 2009, 81:319-327.
13. Harris W.S., Shearer G.C. Omega-6 fatty acids and cardiovascular disease: friend, not foe?. Circulation 2014, 130:1562-1564.
14. Hall J.A., Picton R.A., Skinner M.M., Jewell D.E., Wander R.C. The (n-3) fatty acid dose, independent of the (n-6) to (n-3) fatty acid ratio, affects the plasma fatty acid profile of normal dogs. J. Nutrition 2006, 136:2338-2344.
15. Hansen R.A., Harris M.A., Pluhar G.E., et al. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J. Nutr. Biochem. 2008, 19:101-108.
16. Hudson J.T., Slater M.R., Taylor L., Scott H.M., Kerwin S.C. Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs. Am. J Vet. Res. 2004, 65:1634-1643.
17. Hielm-Bjorkman A.K., Kapatkin A.S., Rita H.J. Reliability and validity of a visual analogue scale used by owners to measure chronic pain attributable to osteoarthritis in their dogs. Am. J Vet. Res. 2011, 72:601-607.
18. Conzemius M.G., Evans R.B. Caregiver placebo effect for dogs with lameness from osteoarthritis. J. Am. Veter-. Med. Assoc. 2012, 241:1314-1319.
19. Brown D.C., Boston R.C., Coyne J.C., Farrar J.T. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J. Am. Veter-. Med. Assoc. 2008, 233:1278-1283.
20. Rialland P., Bichot S., Moreau M., et al. Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis. Veter-. Res. 2012, 8:162.
21. Brown D.C. The Canine Orthopedic Index. Step 2: Psychometric testing. Veter-. Surg.: Vet. Surg. 2014, 43:241-246.
22. Brown D.C. The Canine Orthopedic Index. Step 1: Devising the items. Veter-. Surg.: Vet. Surg. 2014, 43:232-240.
23. Brown zD.C. The Canine Orthopedic Index. Step 3: Responsiveness testing. Veter-. Surg.:Vet. Surg. 2014, 43:247-254.
24. Hielm-Bjorkman A.K., Rita H., Tulamo R.M. Psychometric testing of the Helsinki chronic pain index by completion of a questionnaire in Finnish by owners of dogs with chronic signs of pain caused by osteoarthritis. Am. J. Vet. Res. 2009, 70:727-734.
25. Hielm-Bjorkman A.K., Kuusela E., Liman A., et al. Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J. Am. Veter-. Med. Assoc. 2003, 222:1552-1558.
26. Vandeweerd J.M., Coisnon C., Clegg P., et al. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. J. Veter-. Intern. Med. 2012, 26:448-456.
27. Perea S. Nutritional management of osteoarthritis. Compend.: Contin. Educ. Veter-. 2012, 34:E4.
28. Budsberg S.C., Bartges J.W. Nutrition and osteoarthritis in dogs: does it help?. Veter-. Clin. North Am. - Small Anim. Pract. 2006, 36:1307-1323.
29. Bennett D., Zainal Ariffin S.M., Johnston P. Osteoarthritis in the cat: how should it be managed and treated?. J. Feline Med. Surg. 2012, 14:76-84.
30. Bauer J.E. Responses of dogs to dietary omega-3 fatty acids. J. Am. Veter-. Med. Assoc. 2007, 231:1657-1661.
31. Curtis C.L., Rees S.G., Little C.B., et al. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 2002, 46:1544-1553.
32. Lascelles B.D., King S., Roe S., Marcellin-Little D.J., Jones S. Expression and activity of COX-1 and 2 and 5-LOX in joint tissues from dogs with naturally occurring coxofemoral joint osteoarthritis. J Orthop. Res. 2009, 27:1204-1208.
33. J. Dyerberg, P. Madsen, J.M. Møller, I. Aardestrup, E.B. Schmidt. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids;83: pp. 137-141.
34. Ahlstrom O.K.A., Vhile S.G., et al. Fatty acid composition in commercial dog food. J Nutr. 2004, 134:2145-2147.
35. Filburn C.R., Griffin D. Canine plasma and erythrocyte response to a docosahexaenoic acid-enriched supplement: characterization and potential benefits. Veter-. Ther. 2005, 6:29-42.
36. Stoeckel K., Nielsen L.H., Fuhrmann H., Bachmann L. Fatty acid patterns of dog erythrocyte membranes after feeding of a fish-oil based DHA-rich supplement with a base diet low in n-3 fatty acids versus a diet containing added n-3 fatty acids. Acta Veter-. Scand. 2011, 53:57.
37. Leaf A., Xiao Y.F., Kang J.X., Billman G.E. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J. Membr. Biol. 2005, 206:129-139.
38. Sun Q., Ma J., Campos H., Hankinson S.E., Hu F.B. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am. J. Clin. Nutr. 2007, 86:74-81.
39. Stanford J.L., King I., Kristal A.R. Long-term storage of red blood cells and correlations between red cell and dietary fatty acids: Results from a pilot study. Nutr. Cancer 1991, 16:183-188.